Efficacy of magnesium sulphate in prevension of fits in severe pre-eclampsia
APMC-Annals of Punjab Medical College. 2011; 5 (2): 111-114
em En
| IMEMR
| ID: emr-175222
Biblioteca responsável:
EMRO
Objective: To evaluate the efficacy of magnesium sulphate as prophylactic agent in prevention of fits in severe pre-eclampsia
Study Design: Interventional Quasi experimental study
Setting: Department of Obstetrics and Gynaecology, Punjab Medical College and affiliated hospitals, Faisalabad
Subject: Sixty patients of severe pre-eclampsia fulfilling the inclusion and exclusion criteria
Main Outcome Measures: Occurrence of fit in case and control group, side effects of the drug like flushing, diminishing of reflexes, respiratory depression and hypotension in the case group
Method: Sixty patients with severe pre-eclampsia were divided into two groups: Group A was taken as case and treated with MgSO[4], group B was taken as control and was not given MgSO[4]
Results: Out of the 30 patients treated with MgSo[4] none [0%] had eclampsia in group A. In group B 4 [13.3%] patients developed eclampsia. Side effects of the drug were looked for in group A. Flushing was seen in 6 [20%] patients diminishing of reflexes was deserved in 1 [3.3%] patient
Conclusion: MgSO[4] is an effective drug for prevention of fits in patient of severe preeclampsia
Study Design: Interventional Quasi experimental study
Setting: Department of Obstetrics and Gynaecology, Punjab Medical College and affiliated hospitals, Faisalabad
Subject: Sixty patients of severe pre-eclampsia fulfilling the inclusion and exclusion criteria
Main Outcome Measures: Occurrence of fit in case and control group, side effects of the drug like flushing, diminishing of reflexes, respiratory depression and hypotension in the case group
Method: Sixty patients with severe pre-eclampsia were divided into two groups: Group A was taken as case and treated with MgSO[4], group B was taken as control and was not given MgSO[4]
Results: Out of the 30 patients treated with MgSo[4] none [0%] had eclampsia in group A. In group B 4 [13.3%] patients developed eclampsia. Side effects of the drug were looked for in group A. Flushing was seen in 6 [20%] patients diminishing of reflexes was deserved in 1 [3.3%] patient
Conclusion: MgSO[4] is an effective drug for prevention of fits in patient of severe preeclampsia
Buscar no Google
Índice:
IMEMR
Idioma:
En
Revista:
Ann. Punjab Med. Coll.
Ano de publicação:
2011